Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates

Amylyx Pharmaceuticals, Inc. (AMLX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of$ 0.24. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -291.67%. A quarter ago, it was expected that this company would post earnings of$ 0.20 per share when it actually produced earnings of $0.07, delivering a surprise of -65%.Over the last four quarters, the company h ...